References
- Bloom B, Jones LI, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2012. National Center for Health Statistics. Vital Health Stat. 10 2013;258:1–81.
- Healthcare Cost and Utilization Project (HCUP). Content last reviewed February 2017. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/research/data/hcup/index.html
- Roemer, M. Health Care Expenditures for the Five Most Common Children's Conditions, 2008: Estimates for U.S. Civilian Noninstitutionalized Children, Ages 0–17. Statistical Brief #349. December 2011. Agency for Healthcare Research and Quality, Rockville, MD. http://www.meps.ahrq.gov/mepsweb/data_files/publications/st349/stat349.pdf
- Akinbami LJ, Moorman JE, Garbe PL, Sondik EJ. Status of childhood asthma in the United States, 1980–2007. Pediatrics. 2009;123(Supplement 3):S131–S145.
- Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM. Economic burden of asthma: a systematic review. BMC Pulm Med. 2009;9:24.
- Szefler SJ, Zeiger RS, Haselkorn T, Mink DR, Kamath TV, Fish JE, Chipps BE. Economic burden of impairment in children with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol. 2011;107:110–119.
- National Heart, Lung, and Blood Institute, National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Full Report 2007. Publication 97-4051. Bethesda, MD: National Institutes of Health; 2007.
- Kerem E, Levison H, Schuh S, O'Brodovich H, Reisman J, Bentur L, Canny GJ. Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma. J Pediatr 1993;123:313–317.
- Castro-Rodriguez JA, Rodrigo GJ. β-Agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis. J Pediatr 2004;145:172–177.
- Cates CJ, Welsh EJ, Rowe BH. Holding chambers (spacers) versus nebulizers for beta-agonist treatment of acute asthma. Cochrane Database of Systematic Reviews 2013, Issue 9. Art. No.: CD000052. DOI: 10.1002/14651858.CD000052.pub3.
- Gorelick MH, Stevens MW, Schultz TR, Scribano PV. Performance of a novel clinical score, the Pediatric Asthma Severity Score (PASS), in the evaluation of acute asthma. Acad Emerg Med 2004;11:10–18.
- Krebs SE, Flood RG, Peter JR, Gerard JM. Evaluation of a high-dose continuous albuterol protocol for treatment of pediatric asthma in the emergency department. Pediatr Emerg Care 2013;29:191–196.
- Camargo Jr CA, Spooner C, Rowe BH. Continuous versus intermittent beta-agonists for acute asthma. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD001115. DOI: 10.1002/14651858.CD001115.
- Hampers LC, Cha S, Gutglass DJ, Binns HJ, Krug SE. Fast track and the pediatric emergency department: resource utilization and patients outcomes. Acad Emerg Med 1999;6:1153–1159.
- Schuh, S. Johnson DW, Stephens D, Callahan S, Winders P, Canny G. Comparison of albuterol delivered by a metered dose in haler with spacer versus a nebulizer in children with mild acute asthma. J Pediatrics 1999;135:22–27.
- Abaya R, Jones L, Zorc JJ. Dexamethasone compared to prednisone for the treatment of children with acute asthma exacerbations. Pediatr Emerg Care 2018;34:53–58.
- Chassin MR, Loeb JM. The ongoing quality improvement journey: next stop, high reliability. Health Affairs 2011;30:559–568.